173 related articles for article (PubMed ID: 37884429)
1. Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk.
van Gerwen M; Colicino E; Guan H; Dolios G; Nadkarni GN; Vermeulen RCH; Wolff MS; Arora M; Genden EM; Petrick LM
EBioMedicine; 2023 Nov; 97():104831. PubMed ID: 37884429
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
Madrigal JM; Troisi R; Surcel HM; Öhman H; Kivelä J; Kiviranta H; Rantakokko P; Koponen J; Medgyesi DN; Kitahara CM; McGlynn KA; Sampson J; Albert PS; Ward MH; Jones RR
Int J Cancer; 2024 Mar; 154(6):979-991. PubMed ID: 37902275
[TBL] [Abstract][Full Text] [Related]
3. A Nested Case-Control Study of Serum Per- and Polyfluoroalkyl Substances and Testicular Germ Cell Tumors among U.S. Air Force Servicemen.
Purdue MP; Rhee J; Denic-Roberts H; McGlynn KA; Byrne C; Sampson J; Botelho JC; Calafat AM; Rusiecki J
Environ Health Perspect; 2023 Jul; 131(7):77007. PubMed ID: 37458713
[TBL] [Abstract][Full Text] [Related]
4. Per- and polyfluoroalkyl substances and the associated thyroid cancer risk: A case-control study in China.
Li H; Yang M; Yang J; Seery S; Ma C; Liu Y; Zhang X; Li A; Guo H
Chemosphere; 2023 Oct; 337():139411. PubMed ID: 37419160
[TBL] [Abstract][Full Text] [Related]
5. A prospective nested case-control study of serum concentrations of per- and polyfluoroalkyl substances and aggressive prostate cancer risk.
Rhee J; Barry KH; Huang WY; Sampson JN; Hofmann JN; Silverman DT; Calafat AM; Botelho JC; Kato K; Purdue MP; Berndt SI
Environ Res; 2023 Jul; 228():115718. PubMed ID: 36958379
[TBL] [Abstract][Full Text] [Related]
6. Per- and polyfluoroalkyl substances (PFAS) and thyroid hormone measurements in dried blood spots and neonatal characteristics: a pilot study.
Rosen Vollmar AK; Lin EZ; Nason SL; Santiago K; Johnson CH; Ma X; Godri Pollitt KJ; Deziel NC
J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):737-747. PubMed ID: 37730931
[TBL] [Abstract][Full Text] [Related]
7. Assessing exposures to per- and polyfluoroalkyl substances in two populations of Great Lakes Basin fish consumers in Western New York State.
Liu M; Nordstrom M; Forand S; Lewis-Michl E; Wattigney WA; Kannan K; Wang W; Irvin-Barnwell E; Hwang SA
Int J Hyg Environ Health; 2022 Mar; 240():113902. PubMed ID: 34915281
[TBL] [Abstract][Full Text] [Related]
8. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
[TBL] [Abstract][Full Text] [Related]
9. Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years.
Dunder L; Lind PM; Salihovic S; Stubleski J; Kärrman A; Lind L
Environ Res; 2022 Aug; 211():112903. PubMed ID: 35231461
[TBL] [Abstract][Full Text] [Related]
10. Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis.
Zhan W; Qiu W; Ao Y; Zhou W; Sun Y; Zhao H; Zhang J
Environ Health Perspect; 2023 May; 131(5):57001. PubMed ID: 37134253
[TBL] [Abstract][Full Text] [Related]
11. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum perfluoroalkyl substance mixtures and thyroid hormone concentrations in maternal and cord sera: The HOME Study.
Lebeaux RM; Doherty BT; Gallagher LG; Zoeller RT; Hoofnagle AN; Calafat AM; Karagas MR; Yolton K; Chen A; Lanphear BP; Braun JM; Romano ME
Environ Res; 2020 Jun; 185():109395. PubMed ID: 32222633
[TBL] [Abstract][Full Text] [Related]
13. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort.
Goodrich JA; Walker D; Lin X; Wang H; Lim T; McConnell R; Conti DV; Chatzi L; Setiawan VW
JHEP Rep; 2022 Oct; 4(10):100550. PubMed ID: 36111068
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy Per- and Polyfluoroalkyl Substance Concentrations and Postpartum Health in Project Viva: A Prospective Cohort.
Mitro SD; Sagiv SK; Fleisch AF; Jaacks LM; Williams PL; Rifas-Shiman SL; Calafat AM; Hivert MF; Oken E; James-Todd TM
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3415-26. PubMed ID: 32620010
[TBL] [Abstract][Full Text] [Related]
15. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
[TBL] [Abstract][Full Text] [Related]
16. Prenatal exposure to Per- and polyfluoroalkyl substances and adiposity measures of children at 4 and 6 years: A prospective birth cohort in China.
Sun S; Xie Z; Song X; Wen S; Yuan W; Miao M; Ji H; Liang H
Ecotoxicol Environ Saf; 2024 Jan; 269():115751. PubMed ID: 38042132
[TBL] [Abstract][Full Text] [Related]
17. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
18. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.
Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J
Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790
[TBL] [Abstract][Full Text] [Related]
19. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
20. Association of exposure to perfluoroalkyl substances and risk of the acute coronary syndrome: A case-control study in Shijiazhuang Hebei Province.
Li H; Chen J; Jingchao Lu ; Yang J; Tan Z; Li L; Xiao F; An Z; Ma C; Liu Y; Wang L; Zhang X; Guo H
Chemosphere; 2023 Feb; 313():137464. PubMed ID: 36495974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
